ResMedMEX:RMD 99 FCF Yield % is 5.98 as of Jun. 28, 2026, which is 117% above its 10-year median of 2.75. GuruFocus rates MEX:RMD with a GF Score™ of 99/100 and a GF Value™ of MXN5,059.75 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 855 Medical Devices & Instruments companies, ResMed ranks better than 85.61% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, ResMed's Trailing 12-Month Free Cash Flow is MXN31,868 Mil, and Market Cap is MXN508,965 Mil. Therefore, ResMed's FCF Yield % for today is 5.98%.
The historical rank and industry rank for ResMed's FCF Yield % or its related term are showing as below:
MEX:RMD'
s FCF Yield % Range Over the Past 10 Years
Min: 0.55 Med: 2.75 Max: 6.32
Current: 5.98
During the past 13 years, the highest FCF Yield % of ResMed was 6.32%. The lowest was 0.55%. And the median was 2.75%.
MEX:RMD's FCF Yield % is ranked better than 85.61% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs MEX:RMD: 5.98
ResMed's FCF Margin % for the quarter that ended in Mar. 2026 was 35.95%.
ResMed FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
ResMed FCF Yield % Related Terms
ResMed FCF Yield % Historical Data
* Premium members only.
The historical data trend for ResMed's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ResMed's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ResMed FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's FCF Yield % distribution charts can be found below:
* The bar in red indicates where ResMed's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ResMed (MEX:RMD) has a FCF Yield % of 5.98 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on ResMed and its competitors. This is 117% above median its historical median of 2.75. Over the past decade, ResMed's FCF Yield % has ranged from 0.55 to 6.32. According to the industry distribution chart, ResMed ranks #123 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 14.4%.
Is ResMed's FCF Yield % too high?
ResMed's current FCF Yield % of 5.98 is 117% above median its 10-year median of 2.75. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 6.32. Based on the distribution chart, ResMed ranks #123 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, ResMed has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ResMed's FCF Yield % compare to MDLN and WST?
According to the Medical Devices & Instruments industry distribution chart, ResMed ranks #123 out of 855 companies for FCF Yield %. This places ResMed in the top 14% of its industry — outperforming the majority of peers. Historically, ResMed's own FCF Yield % has ranged from 0.55 to 6.32 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on ResMed and its competitors. ResMed's current FCF Yield % is 5.98, which is 117% above median its own 10-year median of 2.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ResMed stock overvalued right now?
Based on GuruFocus' analysis, ResMed (MEX:RMD) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN5,059.75, compared to a current price of MXN3,716.10 — trading 26.6% below its estimated fair value. The current FCF Yield % is 5.98, which is 117% above median its 10-year median of 2.75. ResMed's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For ResMed (MEX:RMD), the current FCF Yield % is 5.98 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ResMed (MEX:RMD) Overvalued in 2026?
Based on GuruFocus' analysis, ResMed stock appears to be undervalued.
The current stock price of MXN3,716.10 is trading 26.6% below its estimated GF Value™ of MXN5,059.75.
GuruFocus considers ResMed to be Modestly Undervalued.
Key valuation signals for MEX:RMD:
FCF Yield %: 5.98 (117% above median its 10-year median of 2.75)
GF Value™: MXN5,059.75 vs. price of MXN3,716.10 (26.6% below fair value)
No single metric tells the full story. See the MEX:RMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
99GF Score
Get the complete analysis for MEX:RMD
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:RMD has been successfully added to your 
